Postpartum NSAIDS and Maternal Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT03824119

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03824119
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03824119. Randomized; no masking; primary purpose treatment. Start 2018-12-11 (actual); primary completion 2022-12-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Postpartum NSAIDS and Maternal Hypertension
Condition
Preeclampsia
Condition
Gestational Hypertension
Condition
Superimposed Preeclampsia
Condition
Chronic Hypertension in Obstetric Context
Intervention (Drug)
Ibuprofen 600 mg
Intervention (Other)
Standard Postpartum Care without NSAIDs
Lead sponsor
University of Southern California (class: other)

Record details

Record id
cardio:ct-nct03824119
Content hash
cf1069ca68617865f159339e320ecb4a1647313b835efa344e77a114bf2965dc